Nonpsychoactive, neuroprotective cannabinoids available for licensing from NIH Jan. 7, 1999 No Comments
Novel compounds synthesized at SmithKline Beecham act at several 5-HT receptor subtypes Jan. 4, 1999 No Comments
First U.S. marketing approval for Cephalon: Provigil cleared for narcolepsy-associated EDS Dec. 29, 1998 No Comments
YM-872: neuroprotective effects in animal model indicate potential in acute ischemic stroke Dec. 29, 1998 No Comments
RSS